Related Experiment Video
Updated: Mar 27, 2026

10:42
A Free-breathing fMRI Method to Study Human Olfactory Function
Published on: July 30, 2017
10.2K
Altered temporal dynamics of intrinsic brain activity in mild cognitive impairment with olfactory dysfunction
Xuanzi Li1, Xiangzhu Zeng1, Jiafu Li1,2
1The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
Journal of Alzheimer'S Disease : JAD
|March 25, 2026
Summary
Mild cognitive impairment with odor identification impairment shows altered brain activity. These changes in brain networks are linked to cognitive and olfactory deficits, particularly in the precuneus.
Area of Science:
- Neuroscience
- Cognitive Science
- Medical Imaging
Background:
- Odor identification (OI) impairment is a risk factor for Alzheimer's disease (AD) in individuals with mild cognitive impairment (MCI).
- Understanding the neural mechanisms of OI impairment in MCI is crucial for early diagnosis and intervention.
- Dynamic resting-state functional magnetic resonance imaging (rs-fMRI) offers insights into brain network aberrations.
Purpose of the Study:
- To investigate dynamic intrinsic brain activity in MCI patients with and without OI impairment.
- To correlate dynamic neural signatures with cognitive and olfactory function.
- To identify potential neural mediators linking olfactory deficits and cognitive decline in MCI.
Main Methods:
- Analyzed dynamic metrics (dfALFF, dALFF, dDC, dReHo) in 194 participants (97 MCI, 97 healthy controls [HC]).
- Compared MCI with OI impairment (MCI-OII) group against MCI without OI impairment (MCI-NOII) and HC groups.
- Correlated dynamic brain activity metrics with cognitive performance and OI test scores.
Main Results:
- MCI-OII patients exhibited significant cognitive deficits across all domains compared to HC and MCI-NOII groups.
- Elevated variability in dALFF, dfALFF, dDC, and dReHo was observed in brain regions including the fusiform gyrus, insula, precuneus, and cingulate cortex in MCI-OII.
- Dynamic brain activity metrics significantly correlated with olfactory and cognitive scores, with right precuneus dReHo mediating the link between olfactory function and memory recall.
Conclusions:
- MCI patients with OI impairment display widespread disruptions in dynamic brain activity.
- These neural alterations are associated with clinical deficits in cognition and olfaction.
- Dynamic regional homogeneity in the precuneus may play a role in the relationship between olfactory and cognitive decline in MCI.
Related Concept Videos
Olfaction
49.8K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
49.8K
Olfactory Receptors: Location and Structure
14.3K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
14.3K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K

